🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Vaccines are used to prevent infectious diseases worldwide. Unfortunately, ...
Status
Completed
Location
Radboud University
Start Date
2021-09-20
Trial ID
NCT05082688
The aim of this study is to assess the immunogenicity, safety and reactogen...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-10-14
Trial ID
NCT05568797
Treatments Being Tested
This study evaluates whether priming influenza naive infants, age six to 23...
Status
Completed
Location
Vaccine Evaluation Center, BC Children's Hospital
Start Date
2018-11-01
Trial ID
NCT03669627
Treatments Being Tested
A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical S...
Status
Completed
Location
MHAT St. Ekaterina
Start Date
2016-09-30
Trial ID
NCT02587221
This Phase 2, randomized, observer-blind, dose-confirmation clinical study ...
Status
Completed
Location
AMR Tempe
Start Date
2022-08-25
Trial ID
NCT05501561
Treatments Being Tested
The purpose of this study is to assess the reactogenicity, safety and immun...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-08
Trial ID
NCT03275389
This is a randomized, un-blinded, Phase II study in males and non-pregnant ...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic
Start Date
2018-02-20
Trial ID
NCT03318315
This study will evaluate the relative vaccine effectiveness of quadrivalent...
Status
Recruiting
Location
Kaiser Permanente Northern California (entire region)
Start Date
2023-08-17
Trial ID
NCT06029933
Safety, Immunogenicity of an Adjuvanted Quadrivalent Subunit Influenza Viru...
Status
Completed
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02255409
To study the effects of age on the immune system's response to flu vaccine ...
Status
Completed
Location
Vanderbilt University Medical Center
Start Date
2019-10-21
Trial ID
NCT04077424
Treatments Being Tested